POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
Enacted

Utah Law Automatically Reschedules FDA-Approved Schedule I Pharmaceuticals to Match Federal Schedules

Original title: Controlled Substance Scheduling Amendments

Last action · March 24, 2026: Governor SignedSponsors: Evan Vickers and 1 other

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Does

Utah law now allows for the automatic rescheduling of any of a if that composition is rescheduled under federal law. This change takes effect on May 6, 2026.

Why it matters

Changes state-level drug classification processes so that FDA-approved pharmaceutical preparations mirror federal schedules without requiring separate state legislative action. This affects medical providers, pharmacies, and patients handling specific pharmaceutical drugs in Utah.

Background
  • State controlled substance acts list drugs across multiple schedules to regulate their medical use, availability, and potential for abuse. context
  • The federal Controlled Substances Act governs drug scheduling at the national level through the DEA and FDA. context

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

patients

Patients utilizing pharmaceutical compositions of controlled substances see their access governed by state schedules that automatically mirror federal classifications.

Directly affected

healthcare providers

Medical professionals prescribing pharmaceutical compositions must comply with state schedules that automatically update based on federal actions.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What triggers the automatic rescheduling of a pharmaceutical drug under this law?
A of a is automatically rescheduled if the federal government reschedules it to a schedule that is not Schedule I.
When does this new law take effect?
The bill takes effect on May 6, 2026.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Current status: Signed into law.

Procedural history

44 actions
  1. Mar 24, 2026Lieutenant Governor's office for filingEnrolled
    Governor Signed
  2. Mar 16, 2026Senate
    Senate/ to Governor
  3. Mar 16, 2026Senate
    Senate/ received enrolled bill from Printing
  4. Mar 5, 2026Senate
    Senate/ enrolled bill to Printing
  5. Mar 5, 2026Senate Secretary
    Enrolled Bill Returned to House or Senate
  6. Mar 2, 2026Legislative Research and General Counsel / Enrolling
    Draft of Enrolled Bill Prepared
Show 38 earlier actions
  1. Mar 2, 2026Legislative Research and General Counsel / Enrolling
    Bill Received from Senate for Enrolling
  2. Feb 26, 2026Senate
    Senate/ signed by President/ sent for enrolling
  3. Feb 26, 2026Senate
    Senate/ received from House
  4. Feb 26, 2026House
    House/ to Senate
  5. Feb 26, 2026House
    House/ signed by Speaker/ returned to Senate
  6. Feb 26, 2026House
    House/ received from Senate
  7. Feb 26, 2026Senate
    Senate/ to House
  8. Feb 26, 2026Senate
    Senate/ concurs with House amendment
  9. Feb 25, 2026Senate
    Senate/ placed on Concurrence Calendar
  10. Feb 25, 2026Senate
    Senate/ received from House
  11. Feb 25, 2026House
    House/ to Senate
  12. Feb 25, 2026HouseFloor
    House/ passed 3rd reading
  13. Feb 25, 2026House
    House/ floor amendment
  14. Feb 25, 2026House
    House/ 3rd reading
  15. Feb 19, 2026House
    House/ 2nd reading
  16. Feb 19, 2026House
    House/ committee report favorable
  17. Feb 18, 2026House
    House Comm - Favorable Recommendation
  18. Feb 12, 2026HouseCommittee
    House/ to standing committee
  19. Feb 10, 2026HouseIntroduced
    House/ 1st reading (Introduced)
  20. Feb 10, 2026House
    House/ received from Senate
  21. Feb 10, 2026Senate
    Senate/ to House
  22. Feb 10, 2026SenateFloor
    Senate/ passed 3rd reading
  23. Feb 10, 2026Senate
    Senate/ 3rd reading
  24. Feb 9, 2026SenateFloor
    Senate/ passed 2nd reading
  25. Feb 9, 2026Senate
    Senate/ 2nd reading
  26. Jan 27, 2026Senate
    Senate/ placed on 2nd Reading Calendar
  27. Jan 27, 2026Senate
    Senate/ committee report favorable
  28. Jan 26, 2026Senate
    Senate Comm - Favorable Recommendation
  29. Jan 20, 2026SenateCommittee
    Senate/ to standing committee
  30. Jan 20, 2026Senate
    Senate/ received fiscal note from Fiscal Analyst
  31. Jan 20, 2026Released
    LFA/ fiscal note publicly available for SB0083
  32. Jan 20, 2026SenateIntroduced
    Senate/ 1st reading (Introduced)
  33. Jan 16, 2026Version Sponsor
    LFA/ fiscal note sent to sponsor for SB0083
  34. Jan 12, 2026Senate
    Senate/ received bill from Legislative Research
  35. Jan 6, 2026Legislative Fiscal Agency
    LFA/ bill sent to agencies for fiscal input for SB0083
  36. Jan 6, 2026Legislative Fiscal Analyst
    LFA/ bill assigned to staff for fiscal analysis for SB0083
  37. Jan 6, 2026Legislative Research and General Counsel
    Numbered Bill Publicly Distributed
  38. Jan 6, 2026Legislative Research and General Counsel
    Bill Numbered but not Distributed

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Voting Record

Outcome not reportedHouse2/26/2026Utah LegislatureOfficial roll call ↗

Senate/ concurs with House amendment

Total

1

Yes
1
No
0
Present
0
Not voting
0
Abstain
0
Show 5 earlier roll calls
Motion succeededHouse2/25/2026Utah LegislatureOfficial roll call ↗

House/ passed 3rd reading

Total

75

Yes
69
No
0
Present
0
Not voting
6
Abstain
0

How they voted (72)

48 more members
Nicholeen PeckParty not recordedyes
Ryan WilcoxParty not recordedyes
Trevor LeeParty not recordedabsent
Stephanie GriciusParty not recordedyes
Jim DunniganParty not recordedyes
Mike PetersenParty not recordedyes
Ken IvoryParty not recordedyes
Jill KofordParty not recordedyes
Ariel DefayParty not recordedyes
Cheryl ActonParty not recordedyes
Hoang NguyenParty not recordedyes
Carol MossParty not recordedyes
Grant MillerParty not recordedyes
Tom PetersonParty not recordedyes
Anthony LoubetParty not recordedyes
Nelson AbbottParty not recordedyes
Carl AlbrechtParty not recordedyes
Candice PierucciParty not recordedyes
Jake SawyerParty not recordedyes
Melissa BallardParty not recordedyes
Val PetersonParty not recordedabsent
Jake FitisemanuParty not recordedyes
John ArthurParty not recordedyes
Katy HallParty not recordedyes
Cal RobertsParty not recordedabsent
Karen PetersonParty not recordedyes
Verona MaugaParty not recordedyes
Walt BrooksParty not recordedabsent
Christine WatkinsParty not recordedyes
Stephen WhyteParty not recordedyes
Sahara HayesParty not recordedyes
Paul CutlerParty not recordedyes
Tiara AuxierParty not recordedyes
Bridger BolinderParty not recordedyes
Rex ShippParty not recordedyes
Jordan TeuscherParty not recordedyes
Cory MaloyParty not recordedyes
Logan MonsonParty not recordedyes
Karianne LisonbeeParty not recordedabsent
Clint OkerlundParty not recordedyes
Joseph ElisonParty not recordedyes
Tracy MillerParty not recordedyes
Casey SniderParty not recordedyes
Andrew StoddardParty not recordedabsent
Kristen ChevrierParty not recordedyes
Norm ThurstonParty not recordedyes
Lisa ShepherdParty not recordedyes
Mike KohlerParty not recordedyes

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift95% confidence

Alignment with Federal Drug Scheduling

The legislation delegates routine schedule adjustments for FDA-approved pharmaceuticals directly to federal determinations, eliminating the need for independent state statutory updates.

Connected Entities

United States Food and Drug Administration, Drug Enforcement Administration
OrganizationUnited States Food and Drug Administration“Federal agency granting drug approvals”Map →
OrganizationDrug Enforcement Administration“Federal agency scheduling controlled substances”Map →

Sources

Analysis Score

0–100
  • Significance50
    How much this matters to a regular citizen
  • Controversy10
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record